Manufacturer record
Saintlife Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Saintlife Pharmaceuticals Ltd (Uttarakhand) were declared Not of Standard Quality between November 2024 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TA26151, Ramipril Tablets IP 2.5 mg (exp Mar 2028). DTL, Jodhpur (state lab) found it not of standard quality: The sample does not conform to the I.P. with respect to Assay and Dissolution. Listed in the September 2026 alert.
Records by type
15 records linked to Saintlife Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ramipril Tablets IP 2.5 mg | Batch TA26151Mfg Apr 2026 · Exp Mar 2028 | The sample does not conform to the I.P. with respect to Assay and Dissolution.Assay | DTL, JodhpurState lab | Sep 2026 |
| Alprazolam Tablets IP 0.5mg | Batch TA25315Mfg Mar 2025 · Exp Feb 2028 | The sample does not conform to the IP with respect to Dissolution.Dissolution | DTL JaipurState lab | Jul 2026 |
| Ramipril Tablets IP 2.5 mg | Batch TA26022Mfg Jan 2026 · Exp Dec 2027 | The sample does not conform to the IP with respect to Assay.Assay | DTL JaipurState lab | May 2026 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24659Mfg Aug 2024 · Exp Jul 2026 | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Quinine Sulphate Tablets IP 300mg | Batch TA25530Mfg Jun 2025 · Exp May 2027 | The sample does not conform to the IP with respect to in Dissolution.Dissolution | DTL JaipurState lab | Dec 2025 |
| Glimepiride Tablets IP 1 mg | Batch TA24826Mfg Oct 2024 · Exp Sep 2026 | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Nov 2025 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24660Mfg Aug 2024 · Exp Jul 2026 | DefinitionOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24665Mfg Aug 2024 · Exp Jul 2026 | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
| Frusemide Tablets IP 40mg | Batch TA24283Mfg Jul 2024 · Exp Jun 2026 | Sample does not conform to IP specification for Frusemide Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Apr 2025 |
| Bisacodyl Tablets Ip 5mg | Batch TA24366Mfg Jun 2023 · Exp Apr 2026 | Sample does not conform to IP specification for Bisacodyl Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Apr 2025 |
| Bisacodyl Tablets IP 5mg | Batch TA24688Mfg Aug 2024 · Exp Jul 2026 | Sample does not conform to IP specification for Bisacodyl Tablets with respect to Dissolution (Acid medium and Buffer medium)Dissolution | DTL ChennaiState lab | Apr 2025 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24036Mfg Jan 2024 · Exp Dec 2025 | Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamethasone.Other | DTL ChennaiState lab | Dec 2024 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24035Mfg Jan 2024 · Exp Dec 2025 | Sample does not conform to IP Specification for Dexamethasone Tablets with respect to the content of Dexamthasone.Other | DTL ChennaiState lab | Dec 2024 |
| Amitriptyline Tablets IP 25mg | Batch TA24159Mfg Apr 2024 · Exp Mar 2026 | Sample does not conform to IP specification for tablets with respect to Definition.Other | DTL ChennaiState lab | Dec 2024 |
| Dexamethasone Tablets IP 0.5mg | Batch TA24035Mfg Jan 2024 · Exp Dec 2025 | Sample does not conform IP specification for Dexamethasone Tablets with respect to this content of Dexamethasone.Other | DTL ChennaiState lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.